KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Intangibles (2016 - 2025)

Historic Intangibles for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to $54.3 billion.

  • AbbVie's Intangibles fell 1850.22% to $54.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $54.3 billion, marking a year-over-year decrease of 1850.22%. This contributed to the annual value of $60.1 billion for FY2024, which is 801.65% up from last year.
  • As of Q3 2025, AbbVie's Intangibles stood at $54.3 billion, which was down 1850.22% from $57.0 billion recorded in Q2 2025.
  • AbbVie's 5-year Intangibles high stood at $81.3 billion for Q1 2021, and its period low was $54.3 billion during Q3 2025.
  • Over the past 5 years, AbbVie's median Intangibles value was $64.8 billion (recorded in 2023), while the average stood at $66.2 billion.
  • Per our database at Business Quant, AbbVie's Intangibles surged by 34659.12% in 2021 and then plummeted by 1850.22% in 2025.
  • Over the past 5 years, AbbVie's Intangibles (Quarter) stood at $76.0 billion in 2021, then decreased by 11.21% to $67.4 billion in 2022, then decreased by 17.54% to $55.6 billion in 2023, then grew by 8.02% to $60.1 billion in 2024, then fell by 9.58% to $54.3 billion in 2025.
  • Its Intangibles was $54.3 billion in Q3 2025, compared to $57.0 billion in Q2 2025 and $58.5 billion in Q1 2025.